BioMedNewsBreaks Archive - Page 126 of 194

FridaySep 10, 2021 10:24 am

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 23rd Annual Global Investment Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that its president and CEO Eric. A. Adams will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The event is slated to be held virtually from Sept. 13-15, 2021. Adams’ presentation will be available on-demand beginning at 1:00 p.m. ET on Sept. 13, accessible from the H.C. Wainwright events platform at HCW Events. An archived replay will be available on the company’s website immediately following the conference for a period of 90 days. In addition, InMed’s management team will be conducting…

WednesdaySep 08, 2021 12:06 pm

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced its participation at the H.C. Wainwright 23rd Annual Global Investment Conference. Vivos CEO Kirk Huntsman will be presenting at the event beginning at 7:00 a.m. EDT on Monday, Sept. 13, 2021. Interested institutional or retail investors should visit https://ibn.fm/VL1jk to register for the conference and may listen to the company’s presentation online at https://ibn.fm/YuFWj. A replay of the presentation will be available via the Investor Relations page of the company’s website. To…

WednesdaySep 08, 2021 10:46 am

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) to Participate in H.C. Wainwright Global Investment Conference

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, has announced that it will featured at the upcoming H.C. Wainwright 23rd annual Global Investment Conference. The three-day conference is scheduled to begin Sept. 13 and runs through Sept. 15, 2021. MINDCURE president and CEO Kelsey Ramsden will present an overview of the company on Sept. 13, 2021, at 7 a.m. ET. The presentation will be available for interested viewers for 90 days following the conference. To view the presentation, visit https://ibn.fm/whfnm To view the full press release, visit https://ibn.fm/IyoMF About Mind Cure Health…

TuesdaySep 07, 2021 2:34 pm

BioMedNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Positioned as First Mover in Psychedelics Space

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) CEO Greg McKee was recently hosted by Oren Klaff on the Dealmaker Podcast. The interview, which illuminated Tryp Therapeutics’ operations and McKee’s personal story on how he ended up as the CEO, offered some great insights into the future of the psychedelics space, along with what ordinary people can do to take the industry to the next level. A recent article reads, “Mr. McKee cited the benefits that come with the use of psilocybin in treating pain. For one, he discussed their effectiveness without the accompanying risk of addiction associated with opioids. He also…

TuesdaySep 07, 2021 9:32 am

BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase in Subsidiary Holding

AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd., one of its subsidiaries; the increase came after approval was granted by the company audit committee and board of directors. The company announced that in late August 2021 it finalized the share structure registration amendment with the local Administration Management Bureau. Before making the decision, company officials conducted rigorous due diligence that included obtaining financial and legal audits and appraisals by a qualified appraiser. AnPac Bio-Medical Science is a biotechnology company with operations in China and…

FridaySep 03, 2021 11:53 am

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Cannabis Investor Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ("CBN"), will be a featured company in the upcoming Cannabis Industry Virtual Investor Conference, slated for Sept. 8–9, 2021; INM’s presentation is scheduled for Sept. 8 at 1:30 p.m. ET. The two-day conference is an exclusive opportunity for cannabis company leaders to share the vision and mission of their companies and meet with potential investors.The conference is hosted by Virtual Investor Conferences (“VIC”) in partnership with KCSA Strategic Communications. VIC is part of OTC Market Group’s…

ThursdaySep 02, 2021 12:37 pm

BioMedNewsBreaks – Brain Scientific Inc.’s (BRSF) Expanded Vision for Neurology Telemedicine Combines Diagnostic Solutions, AI, ML, and Cloud-Based Infrastructure

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has developed cost-effective and portable proprietary brain diagnostic solutions — the NeuroCap(TM) and NeuroEEG(TM) — that are positioned to disrupt the electroencephalogram (“EEG”) market. With nearly every U.S. state experiencing a neurologist shortfall and experts warning that access to high-level care and diagnosis is immediately required to reduce mental disability, improve patient outcomes and increase the wellbeing of the current pool of neurologists, Brain Scientific aims to support the industry through its diagnostic solutions. A recent article explains: “These portable devices are part of the company’s…

WednesdaySep 01, 2021 11:29 am

BioMedNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright Global Investment Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced that it will present at the H.C. Wainwright Annual Global Investment Conference. The event is slated to be held virtually on Sept. 13-15, 2021. Greg McKee, chairman and CEO of Tryp, will provide an overview of the company and its pipeline including Tryp's Psilocybin-for-Neuropsychiatric Disorders (“PFN”(TM)) program for chronic pain and eating disorder indications. Interested parties should visit https://ibn.fm/AkhYM to register and access the presentation. In addition, Tryp announced that it has granted an…

TuesdayAug 31, 2021 12:13 pm

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Leveraging Strategic Board Appointment to Execute Visionary Strategy

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, recently announced its appointment of Jerry White as an advisor to the company. White has been recognized for his efforts in engaging large audiences to power global movements and is a recognized leader of the International Campaign to Ban Landmines and a co-recipient of the 1997 Nobel Peace Prize. Given his expertise, ambition and successful track record, White is an excellent addition to the company’s advisory board as it focusses on achieving strategic goals while working towards its overall vision. “Never shying away…

MondayAug 30, 2021 3:06 pm

BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Featured in Visual Capitalist Spotlight

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, was recently featured in a company spotlight on the Visual Capitalist. The piece highlights RYAH’s work to leverage data for powerful health solutions and references several drivers behind the company’s success. Among these, the report describes RYAH’s multiple internet-of-things (“IoT”) devices that have produced data for the world’s largest clinical trials in plant-based medicine. In addition, the piece describes the company’s proprietary technology, capacity for custom solutions, its long-term business model, and its positioning…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

BioMedNewsBreaks

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 23rd Annual Global Investment Conference

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) to Participate in H.C. Wainwright Global Investment Conference

BioMedNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Positioned as First Mover in Psychedelics Space

BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase in Subsidiary Holding

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Cannabis Investor Conference

BioMedNewsBreaks – Brain Scientific Inc.’s (BRSF) Expanded Vision for Neurology Telemedicine Combines Diagnostic Solutions, AI, ML, and Cloud-Based Infrastructure

BioMedNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright Global Investment Conference

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Leveraging Strategic Board Appointment to Execute Visionary Strategy

BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Featured in Visual Capitalist Spotlight

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search